PLUVICTO 1000 MBq (Lutetium (177lu) Vipivotide Tetraxetan SOLUTION) 1000 MBq

PLUVICTO 1000 MBq is a radiopharmaceutical solution used in targeted therapy. It contains Lutetium (177Lu) Vipivotide Tetraxetan, designed for intravenous administration. This medication is manufactured by Novartis Pharmaceuticals Canada Inc.

Strength

1000 MBq

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PLUVICTO 1000 MBq is a radiopharmaceutical solution that is used in targeted therapy. It is designed to deliver radiation directly to specific cells in the body. This medication is often used in the treatment of certain types of cancer, where it helps to target and destroy cancer cells. The primary use of PLUVICTO is to provide a targeted approach to therapy, minimizing damage to healthy tissues.

Side Effects

PLUVICTO 1000 MBq may cause various effects, including fatigue, nausea, and changes in blood cell counts. Some individuals may experience pain or swelling at the injection site. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur. The effects of this medication can vary from person to person.

Precautions & Warnings

PLUVICTO 1000 MBq should be handled with care due to its radioactive nature. It is important to follow proper safety protocols when administering this medication. Pregnant women and individuals with certain medical conditions should exercise caution. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

PLUVICTO 1000 MBq may interact with other medications, particularly those that affect blood cell counts or the immune system. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with this medication. Always consult a healthcare provider for personalized advice.

Frequently Asked Questions

PLUVICTO 1000 MBq is used in targeted therapy for certain types of cancer. It delivers radiation directly to specific cells in the body.

PLUVICTO 1000 MBq is administered intravenously. It should be handled with care due to its radioactive nature.

Common effects may include fatigue, nausea, and changes in blood cell counts. Some individuals may experience pain or swelling at the injection site.

Pregnant women and individuals with certain medical conditions should exercise caution. Always consult a healthcare provider before starting any new medication.

Yes, it may interact with medications that affect blood cell counts or the immune system. Always inform your healthcare provider about all medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.